(Q36854132)

16 August 2017

1 reference

title

Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease (English)

1 reference

16 August 2017

1 reference

1 reference

1 reference

Bin Liu

1

1 reference

16 August 2017

Dean E Dluzen

series ordinal

2

1 reference

16 August 2017

publication date

1 July 2007

1 reference

Clinical and Experimental Pharmacology and Physiology

16 August 2017

published in

1 reference

16 August 2017

volume

34

1 reference

16 August 2017

issue

7

1 reference

16 August 2017

page(s)

555-565

1 reference

Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta).

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4 weeks postpartum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Is there a connection between estrogen and Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Postmenopausal estrogen use affects risk for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Short-term effects of high-dose 17beta-estradiol in postmenopausal PD patients: a crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

The effect of estrogen replacement on early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Caffeine, postmenopausal estrogen, and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Risk of Parkinson disease in women: effect of reproductive characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: influence of estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Attenuation of dopamine uptake in vivo following priming with estradiol benzoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Astrocytes, brain aging, and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Developmental and Hormonal Regulation of the Sex Difference in Preprotachykinin Gene Expression in Rat Anterior Pituitaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04616.X

10.1111/J.1440-1681.2007.04616.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference